Javascript must be enabled to continue!
Formulation Development and In-Vitro Evaluation of Transferosomal Gel of Mometasone Furoate
View through CrossRef
The main aim of the study is to formulate and evaluate transferosomal gel formulation for effective topical delivery of Mometasone furoate. The transferosomes was prepared using thin film hydration technique by various proportions of Soya phosphatidylcholine, tween 80. The drug was encapsulated into eight different Transferosomal formulations from F1-F8. The optimized formulation F4 showed small particle size (152.48 nm), entrapment efficiency % EE of 87.16%, zeta potential of -32mV, 0.252 PDI and % Cumulative Drug Release of (97.14%). SEM of optimized Transferosome appeared as spherical, well identified, Unilamellar vesicles. The optimized formulation of Transferosomes was further formulated to transferosomal gel with Carbopol-940 (0.2 to 0.8% w/w), HPMC k15 (0.2 to 0.8% w/w), Propylene glycol, Triethanolamine and Isopropyl alcohol. Among these, F4 formulation with Carbopol-940 0.8%w/w transferosomal gel is the optimized transferosomal gel and showed Spreadability value 0.229±0.01gm.cm/sec, pH value 5.8. The actual drug content of the Transferosomal gel was found to be 98.90%, which represents good content uniformity. The viscosity of optimized Transferosomal gel was found to 55417cps. The percentage drug release for Transferosomal gel was 98.22%. And the formulation was stable throughout the stability studies. This research suggests that Mometasone Furoate loaded transferosomal gel can be potentially used as a transdermal drug delivery system for effective topical delivery.
Keywords: Mometasone Furoate, Transfersomes, Soya phosphatidyl choline and Tween 80.
Society of Pharmaceutical Tecnocrats
Title: Formulation Development and In-Vitro Evaluation of Transferosomal Gel of Mometasone Furoate
Description:
The main aim of the study is to formulate and evaluate transferosomal gel formulation for effective topical delivery of Mometasone furoate.
The transferosomes was prepared using thin film hydration technique by various proportions of Soya phosphatidylcholine, tween 80.
The drug was encapsulated into eight different Transferosomal formulations from F1-F8.
The optimized formulation F4 showed small particle size (152.
48 nm), entrapment efficiency % EE of 87.
16%, zeta potential of -32mV, 0.
252 PDI and % Cumulative Drug Release of (97.
14%).
SEM of optimized Transferosome appeared as spherical, well identified, Unilamellar vesicles.
The optimized formulation of Transferosomes was further formulated to transferosomal gel with Carbopol-940 (0.
2 to 0.
8% w/w), HPMC k15 (0.
2 to 0.
8% w/w), Propylene glycol, Triethanolamine and Isopropyl alcohol.
Among these, F4 formulation with Carbopol-940 0.
8%w/w transferosomal gel is the optimized transferosomal gel and showed Spreadability value 0.
229±0.
01gm.
cm/sec, pH value 5.
8.
The actual drug content of the Transferosomal gel was found to be 98.
90%, which represents good content uniformity.
The viscosity of optimized Transferosomal gel was found to 55417cps.
The percentage drug release for Transferosomal gel was 98.
22%.
And the formulation was stable throughout the stability studies.
This research suggests that Mometasone Furoate loaded transferosomal gel can be potentially used as a transdermal drug delivery system for effective topical delivery.
Keywords: Mometasone Furoate, Transfersomes, Soya phosphatidyl choline and Tween 80.
Related Results
Effects of a Thermosensitive In Situ Gel Containing Mometasone Furoate on a Rat Allergic Rhinitis Model
Effects of a Thermosensitive In Situ Gel Containing Mometasone Furoate on a Rat Allergic Rhinitis Model
Background
Mometasone furoate, one of the second generation intranasal corticosteroids, is currently used in suspension form due to its poor solubility. However...
Formulation, development and characterization of topical organogel of mometasone furoate for the treatment of skin disease
Formulation, development and characterization of topical organogel of mometasone furoate for the treatment of skin disease
Topical glucocorticoid formulations are widely used for effective treatment and control of a variety of dermatoses. Mometasone furoate is a medium potency, synthetic, non-fluorinat...
Formulation and Evaluation of Gentamicin-Loaded Transferosomal Gel
Formulation and Evaluation of Gentamicin-Loaded Transferosomal Gel
Gentamicin is a broad-spectrum antibiotic that is utilized in treating infections caused by strains of Streptococci, Staphylococci, Pseudomonas, and gram-negative bacteria. Gentami...
579. Epidemiological Data Differences between Gel-purified vs. DNA-purified Oral Polio Vaccine in environmental samples
579. Epidemiological Data Differences between Gel-purified vs. DNA-purified Oral Polio Vaccine in environmental samples
Abstract
Background
As wild poliovirus is eradicated, preventing circulation of vaccine-derived poliovirus is top priority. Our ...
Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A Combination Therapy for Asthma
Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A Combination Therapy for Asthma
Abstract:Despite the wide range of available therapies, asthma remains uncontrolled in 40-65% of patients for a number of different reasons. Treatment with an inhaled corticosteroi...
GW24-e1356 The histocompatibility of angiotensin converting enzyme does not promote its function on inhibitory to negative ventricular remodelling
GW24-e1356 The histocompatibility of angiotensin converting enzyme does not promote its function on inhibitory to negative ventricular remodelling
Objectives
Renin-angiontensin-aldosterone system (RAAS) is widely evidenced its point on inhibiting ventricular remodelling post myocardial infarction. The increa...
BOX–BEHNKEN DESIGN APPROACH FOR OPTIMIZATION OF ACECLOFENC LOADED TRANSFEROSOMAL GEL FOR ENHANCED TRANSDERMAL DELIVERY
BOX–BEHNKEN DESIGN APPROACH FOR OPTIMIZATION OF ACECLOFENC LOADED TRANSFEROSOMAL GEL FOR ENHANCED TRANSDERMAL DELIVERY
Objective: The current study aimed to develop and optimize an aceclofenac (ACF)-loaded transferosomal gel for transdermal drug delivery using a Box–Behnken design (BBD), thereby en...
Design, Characterization and Pharmacokinetic–Pharmacodynamic Evaluation of Poloxamer and Kappa-Carrageenan-Based Dual-Responsive In Situ Gel of Nebivolol for Treatment of Open-Angle Glaucoma
Design, Characterization and Pharmacokinetic–Pharmacodynamic Evaluation of Poloxamer and Kappa-Carrageenan-Based Dual-Responsive In Situ Gel of Nebivolol for Treatment of Open-Angle Glaucoma
This study developed a dual-responsive in situ gel of nebivolol (NEB), a selective β-adrenergic antagonist. The gel could achieve sustained concentrations in the aqueous humor to e...

